POPSTAR II is an Australian phase II study recruiting 92 BCR oligometastatic PCa with positive [68Ga]Ga-PSMA-11 or [18F]DCFPyL PET after primary treatment. This evidence concerns the gene BCR and posterior cortical atrophy.